Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild to Moderate Atopic Dermatitis in Two Phase 3 Trials (INTEGUMENT-1 and INTEGUMENT-2). J of Skin [Internet]. 2023 Jul. 17 [cited 2025 Apr. 18];7(4):s220. Available from: https://skin.dermsquared.com/skin/article/view/2195